PROSPECTUS SUPPLEMENT | REGISTRATION NO. 333-44286 |
(To Prospectus dated March 15, 2011)
|
Filed Pursuant to Rule 424(b)(3) |
Name of Company(1)
|
Ticker
|
Share
Amounts |
Primary U.S.
Trading Market |
|||
AEGON N.V.
|
AEG
|
5.2000
|
NYSE
|
|||
Alcatel-Lucent*
|
ALU
|
3.0000
|
NYSE
|
|||
Amdocs Limited
|
DOX
|
3.0000
|
NYSE
|
|||
ARM Holdings, plc*
|
ARMH
|
8.0000
|
NASDAQ GS
|
|||
ASM International N.V.
|
ASMI
|
13.0000
|
NASDAQ GS
|
|||
ASML Holding N.V.
|
ASML
|
6.2222
|
NASDAQ GS
|
|||
AstraZeneca PLC.*
|
AZN
|
4.0000
|
NYSE
|
|||
BP p.l.c.*
|
BP
|
4.0000
|
NYSE
|
|||
Diageo p.l.c.*
|
DEO
|
5.0000
|
NYSE
|
|||
Elan Corporation, p.l.c.*
|
ELN
|
4.0000
|
NYSE
|
|||
LM Ericsson Telephone Company*
|
ERIC
|
3.2000
|
NASDAQ GS
|
|||
GlaxoSmithKline p.l.c.*
|
GSK
|
6.0000
|
NYSE
|
|||
ING Groep N.V.*
|
ING
|
4.0000
|
NYSE
|
|||
Koninklijke Philips Electronics N.V.
|
PHG
|
5.0000
|
NYSE
|
|||
Nokia Corporation*
|
NOK
|
5.0000
|
NYSE
|
|||
Novartis AG*
|
NVS
|
5.0000
|
NYSE
|
|||
Oclaro Inc.
|
OCLR
|
0.2400
|
NASDAQ GM
|
|||
Qiagen N.V.
|
QGEN
|
6.0000
|
NASDAQ GS
|
|||
Repsol YPF, S.A.*
|
REP
|
11.0000
|
NYSE
|
|||
Ryanair Holdings p.l.c.*
|
RYAAY
|
16.0000
|
NASDAQ GS
|
|||
Sanofi-Aventis SA*
|
SNY
|
4.6956
|
NYSE
|
|||
SAP AG*
|
SAP
|
4.0000
|
NYSE
|
|||
Shire plc*
|
SHPGY
|
4.0000
|
NASDAQ GS
|
|||
STMicroelectronics N.V.
|
STM
|
4.0000
|
NYSE
|
|||
Telefonica S.A.*
|
TEF
|
4.5558
|
NYSE
|
|||
Total S.A.*
|
TOT
|
6.0000
|
NYSE
|
|||
UBS AG
|
UBS
|
6.3000
|
NYSE
|
|||
Unilever N.V.
|
UN
|
9.0000
|
NYSE
|
|||
Vodafone Group Public Limited Company*
|
VOD
|
5.2500
|
NASDAQ GS
|
|||
WPP Group plc
|
WPPGY
|
3.0000
|
NASDAQ GS
|